Imaging Diagnostic Interventions of Focal Liver Lesions -When and Why : Review Article

Atanas Dimitrov Hilendarov; Aleksandar Georgiev; Liubomid Tchervenkov

doi:10.58372/2835-6276.1392

Authors

Atanas Dimitrov Hilendarov
Aleksandar Georgiev
Liubomid Tchervenkov

DOI:

https://doi.org/10.58372/2835-6276.1392

Keywords:

Focal Liver lesions, Imaging control, Fine-needle puncture, Fine-needle aspiration Biopsy

Abstract

Purpose: The present study assess factors affecting the success of US and CT-guided liver biopsy of focal lesions on the basis of experience when cytopathologic examination results were available.

Methods and Materials: 175 liver biopsies and punctures in 175 patients(120 male and 55 female) were performed under US or CT control. Lesions ranged in diameter from 9mm to 30 mm. We utilized US guidence in 103(66.02%) cases and CT guidence in 53(33.97%) cases. Ultrasound equipment supplied with 3.5 and 7 MHz linear and convex transducers, MDCT machine and biopsy needles were used. The on-site cytologic evaluation guided the radiologist to continue to another biopsy pass and avoid a nondiagnostic biopsy result.

Results: During a 4-year period we performed FN liver biopsies or punctures in 175 patients (120 males and 55 females) with small (9-30mm) liver lesions. The CT guidance was utilized for biopsy of deep, small liver masses of ultrasonographically non visible and subdiaphragmatically located lesions. Interventional procedures under imaging control of small focal liver lesions had a sensitivity of 97.76 %, specificity of 80.48 % and accuracy of 93.71 %. The PPV (positive predictive value) is 94.24 % and the NPV (negative predictivе value)–91.66%.

Conclusion: Interventional procedures under imaging (US and CT) control of the small focal liver lesions is a highly reliable, safe, inexpensive invasive procedure with great diagnostic value in suspected HCC less than 2 cm in diameter, liver metastases, as well as all benign tumors without typical findings on either dynamic multi-detector CT or CEUS.

References

Hamer OW, Schlottmann K, Sirlin CB, Feuerbach S. Technology insight: advances in liver imaging. Nat Clin Pract Gastroenterol Hepatol 2007; 4: 215-228 [PMID: 17404589]

Pandharipande PV, Krinsky GA, Rusinek H, Lee VS. Perfusion imaging of the liver: current challenges and future goals. Radiology 2005; 234: 661-673 [PMID: 15734925]

Bilgili Y, Firat Z, Pamuklar E, Unal B, Hyslop W, Rivero H, Semelka RC. Focal liver lesions evaluated by MR imaging. Diagn Interv Radiol 2006; 12: 129-135 [ PMID: 15734925]

Tchelepi H, Ralls PW. Ultrasound of focal liver masses. Ultrasound Q 2004; 20: 155-169 [PMID: 15602218]

Dietrich CF. Characterisation of focal liver lesions with contrast enhanced ultrasonography. Eur J Radiol 2004; 51 Suppl: S9-S17 [PMID: 15234021]

Konopke R, Bunk A, Kersting S. The role of contrast-enhanced ultrasound for focal liver lesion detection: an overview. Ultrasound Med Biol 2007; 33: 1515-1526 [PMID: 17618038]

Quaia E, Calliada F, Bertolotto M, Rossi S, Garioni L, Rosa L, Pozzi-Mucelli R. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 2004; 232: 420-430 [PMID: 15286314]

Wen YL, Kudo M, Zheng RQ, Ding H, Zhou P, Minami Y, Chung H, Kitano M, Kawasaki T, Maekawa K. Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio. AJR Am J Roentgenol 2004; 182: 1019-1026[PMID: 15039180]

D'Onofrio M, Rozzanigo U, Masinielli BM, Caffarri S, Zogno A, Malagò R, Procacci C. Hypoechoic focal liver lesions: characterization with contrast enhanced ultrasonography. J Clin Ultrasound 2005; 33: 164-172[PMID: 15856516]

Buscarini L, Fornari F, Bolondi L, et al. Ultrasound-guided fine-needle biopsy of focal liver lesions: techniques, diagnostic accuracy and complications. A retrospective study on 2091 biopsies. J Hepatol 1990; 11: 344–8 [PMID: 2290025]

Nazarian LN, Feld RI, Herrine SK, et al. Safety and efficacy of sonographically guided random core biopsy for diffuse liver disease. J Ultrasound Med 2000; 19(8): 537–41[PMID: 10944039]

Thanos L, Zormpala A, Papaioannou G, Malagari K, Brountzos E, Kelekis D. Safety and efficacy of percutaneous CT-guided liver biopsy using an 18-gauge automated needle. Eur J Intern Med 2005; 16(8): 571–574.[ PMID: 16132435]

Yu SC, Liew CT, Lau WY, Leung TW, Metreweli C. US-guided percutaneous biopsy of small (< or = 1-cm) hepatic lesions. Radiology 2001;218(1):195–199 [PMID: 11152801]

Jhala NC, Eltoum IA, Eloubeidi MA, et al. Providing on-site diagnosis of malignancy on endoscopic-ultrasound-guided fine-needle aspirates: should it be done? Ann Diagn Pathol 2007;11(3):176–181[PMID: 17498591]